ClearBridge Investments’s Nymox Pharmaceutical Corp NYMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-1,000
Closed -$4K 1020
2020
Q2
$4K Hold
1,000
﹤0.01% 929
2020
Q1
$2K Hold
1,000
﹤0.01% 1021
2019
Q4
$2K Hold
1,000
﹤0.01% 1071
2019
Q3
$2K Hold
1,000
﹤0.01% 1086
2019
Q2
$1K Hold
1,000
﹤0.01% 1089
2019
Q1
$2K Hold
1,000
﹤0.01% 1056
2018
Q4
$1K Hold
1,000
﹤0.01% 1118
2018
Q3
$2K Hold
1,000
﹤0.01% 1114
2018
Q2
$3K Hold
1,000
﹤0.01% 1081
2018
Q1
$4K Hold
1,000
﹤0.01% 1066
2017
Q4
$3K Hold
1,000
﹤0.01% 1095
2017
Q3
$4K Hold
1,000
﹤0.01% 1137
2017
Q2
$4K Hold
1,000
﹤0.01% 1146
2017
Q1
$4K Hold
1,000
﹤0.01% 1106
2016
Q4
$3K Hold
1,000
﹤0.01% 1145
2016
Q3
$3K Hold
1,000
﹤0.01% 1100
2016
Q2
$3K Hold
1,000
﹤0.01% 1044
2016
Q1
$2K Hold
1,000
﹤0.01% 1046
2015
Q4
$3K Hold
1,000
﹤0.01% 1091
2015
Q3
$3K Hold
1,000
﹤0.01% 1146
2015
Q2
$1K Hold
1,000
﹤0.01% 1148
2015
Q1
$1K Hold
1,000
﹤0.01% 1165
2014
Q4
$1K Hold
1,000
﹤0.01% 1166
2014
Q3
$4K Hold
1,000
﹤0.01% 1147
2014
Q2
$5K Hold
1,000
﹤0.01% 1153
2014
Q1
$5K Hold
1,000
﹤0.01% 1112
2013
Q4
$6K Hold
1,000
﹤0.01% 1074
2013
Q3
$7K Hold
1,000
﹤0.01% 1048
2013
Q2
$6K Buy
+1,000
New +$5.07K ﹤0.01% 1045

Other funds holding NYMX

ClearBridge Investments's NYMX Position: Q3 2020 in Review

ClearBridge Investments sold out of Nymox Pharmaceutical Corp (NYMX) in Q3 2020, closing a stake of 1,000 shares — an estimated $4K sold.

ClearBridge Investments first reported a position in NYMX in Q2 2013 and held it in 29 quarters. The position peaked at $7K in Q3 2013. 64 funds tracked by Wall St. Rank hold NYMX as of Q3 2020.

  • ClearBridge Investments reported no remaining Nymox Pharmaceutical Corp position as of Q3 2020 after selling out during the quarter.
  • ClearBridge Investments sold 1,000 Nymox Pharmaceutical Corp shares in Q3 2020, an estimated $4K.
  • ClearBridge Investments first reported a position in Nymox Pharmaceutical Corp in Q2 2013 and held it in 29 quarters.
  • ClearBridge Investments's Nymox Pharmaceutical Corp position peaked at $7K in Q3 2013.
  • 64 funds tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q3 2020.

Based on ClearBridge Investments's 13F filing for Q3 2020, filed 12 Nov 2020.